site map

Downloads

Financial Reports

2010
First Quarter - PDF, 161KB

2009
Annual Report - PDF, 483KB
Third Quarter - PDF, 173KB
Second Quarter - PDF, 965KB
First Quarter - PDF, 403KB

2008
Annual Report - PDF, 7.5MB
Third Quarter - PDF, 417KB
Second Quarter - PDF, 441KB
First Quarter - PDF, 419KB

2007
Annual Report - PDF, 2.9MB
Third Quarter - PDF, 1.88MB
Second Quarter - PDF, 8.25MB
First Quarter - PDF, 1.99MB

2006
Annual Report - PDF, 2.3MB
Third Quarter - PDF, 243KB
Second Quarter - PDF, 161KB
First Quarter - PDF, 135KB

2005
Annual Report - PDF, 1.5MB

2004
Annual Report - PDF, 1.5MB

 

Fact Sheet

Investor Fact Sheet -June 2010

2006 Protox Therapeutics Inc. All Rights Reserved. Legal Disclaimer.

What's New

June 2 2010
Protox Announces Positive Six Month Phase 2B BPH Results

June 1, 2010
Protox to Present Phase 2B BPH Data at the Annual Meeting of the American Urological Association

May 13, 2010
Protox Reports First Quarter 2010 Financial Results

April 29, 2010
Protox Signs $75 Million License Agreement with Kissei for Commercialization of PRX302 in Japan for BPH and Prostate Disease

 

Events

January 11, 2010 - 8:45 am ET
Protox Therapeutics Conference Call - Webcast Link

 

Stock Quote

LAST TRADE:$0.39
TRADE TIME:3:53PM EST
CHANGE:$0.00 (0.00%)
PREV CLOSE: $0.39
OPEN:$0.39
BID:$0.385
ASK:$0.39